Microfluidic Cartridge for Nucleic Acid Stabilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current microfluidic devices are inadequate for rapid, low-cost, and simple nucleic acid sample preparation and analysis, particularly for RNA, due to issues with enzymatic degradation and interference from chaotropic salts, making them unsuitable for point-of-care diagnostics in resource-limited settings.
Innovation Solution
A microfluidic device using a clay mineral and alkaline buffer for sample preparation, which protects nucleic acids from enzymatic and hydrolytic degradation, allowing for simultaneous detection of DNA and RNA targets from complex biological samples without the need for further purification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If commercial RNA stabilization products are used, then RNA integrity is protected, but cost increases and technical complexity increases
Solution Approach 1:
The patent employs a disposable microfluidic cartridge that integrates all RNA stabilization functions into a single-use device. The cartridge contains pre-loaded reagents including silica particles for RNA binding, chaotropic salts for RNase inactivation, and buffers for maintaining RNA integrity throughout the extraction process. This eliminates the need for expensive commercial stabilization products while ensuring RNA integrity through integrated, disposable functionality.
Solution Approach 2:
The patent merges multiple functions (RNA stabilization, RNase inactivation, RNA binding, washing, and elution) into a single integrated microfluidic cartridge. The cartridge combines silica particles, chaotropic salts, and various buffers within a unified device architecture, eliminating the need for separate stabilization steps and commercial products. This integration reduces technical complexity while maintaining RNA integrity through coordinated action of all components.
2Reliability
If refrigeration and freezing are used for RNA stabilization, then RNA integrity is maintained, but device portability is reduced and operational simplicity is compromised
Solution Approach 1:
The microfluidic cartridge is designed to maintain RNA integrity through self-contained chemical stabilization mechanisms that require no external refrigeration or freezing. Chaotropic salts and RNase inhibitors within the cartridge create a chemical environment that naturally prevents RNA degradation at ambient temperatures. The device performs stabilization autonomously through its integrated reagent system, eliminating the need for temperature-controlled storage and simplifying operational procedures for point-of-care use.
3Manufacturing precision
If chaotropic salts are used for RNA extraction, then RNA purification is achieved, but enzymatic activity is inhibited and downstream analysis is interfered with
Solution Approach 1:
The patent segments the extraction process into distinct functional zones within the microfluidic cartridge: a lysis chamber where chaotropic salts initially purify RNA by binding to silica particles, followed by a separate washing chamber that removes chaotropic salt contaminants, and finally an elution chamber that releases purified RNA into a buffer compatible with downstream enzymatic reactions. This spatial segmentation allows temporary use of chaotropic salts for purification while systematically removing their harmful inhibitory effects before analysis.
Solution Approach 2:
The microfluidic design rapidly progresses through the extraction steps, minimizing the time RNA is exposed to chaotropic salts. The integrated flow path quickly moves samples through lysis, binding, washing, and elution stages, reducing the duration of enzymatic inhibition. The rapid throughput allows chaotropic salts to perform their purification function briefly while limiting their opportunity to interfere with downstream enzymatic analysis.
4Reliability
If multiple processing steps are used for sample preparation, then nucleic acid stability is improved, but processing time increases and productivity decreases
Solution Approach 1:
The patent combines multiple nucleic acid stabilization functions into a single integrated microfluidic cartridge that performs lysis, RNA binding to silica particles, RNase inactivation, washing, and elution in one continuous flow process. All steps occur within the single device without transfer between separate instruments or workstations, maintaining nucleic acid stability through coordinated chemical environments while enabling rapid processing suitable for high-throughput point-of-care diagnostics.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device provides stable nucleic acid samples suitable for immediate amplification reactions, enhancing the reliability of diagnostic tests and reducing the complexity and cost of sample preparation, especially in resource-constrained environments.
Implementation Method 1
contacting the sample with a clay mineral
Implementation Method 2
an alkaline buffer for sample preparation, which protects nucleic acids from enzymatic and hydrolytic degradation
Data Source
AI summary
An integrated “lab-on-a-chip” microfluidic device performs nucleic acid sample preparation and diagnostic analysis from test samples containing cells and/or particles. The device analyzes DNA or RNA targets, or both, from a common test sample. Dried and/or liquid reagents necessary for nucleic acid sample preparation and analysis are contained on the device, such that the device only requires addition of test sample. Clay mineral and alkaline buffer reagents are employed for overcoming the problems of nucleic acid degradation and contamination during sample preparation. The device may include a composite filter to separate plasma or serum from other blood constituents when the test sample is a blood product. The microfluidic device utilizes a plurality of microfluidic channels, inlets, valves, membranes, pumps, and other elements arranged in various configurations to manipulate the flow of the liquid sample, in particular, in order to prepare nucleic acids and perform further diagnostic analysis.